Obamacare, Medicare and Biosimilar Drugs and the Price You Pay.
Medicare Part D beneficiaries will pay more for biosimilar drugs (are similar — but not identical — to the brand-name
Read More
Part D/Prescription Drugs
Will the New Medicare Drug Plan Actually Hold Down the Costs of Drugs?
Everyone agrees the Medicare program cannot sustain itself beyond the year 2030 without some sort of intervention on keeping costs
Read MoreRise In Oncologists Working For Hospitals Spurs Higher Chemo Costs: Study
(By Michelle Andrews for Kaiser Health News) If you have cancer, chances are your outpatient chemotherapy treatment costs are higher
Read MoreWe Spent $425 Billion Before Discounts
We spent $425 billion that is before discounts last year on prescription drugs in United States. The overall increase of spending
Read MorePolitical Gridlock Blocks Missouri Database For Fighting Drug Abuse
(By Bram Sable-Smith, Side Effects Public Media in partnership with Kaiser Health News) At Richard Logan’s pharmacy in Charleston, Missouri,
Read MoreMedicare Spent $20.9 Billion on Part B Drugs in 2013
In 2013, Medicare spent $20.9 billion on Part B drugs which particular 9 drugs accounted for 76% of the total
Read MoreMedPAC Votes for Sweeping Revisions to Medicare Part D
(Source – www.policymed.com) The Medicare Payment Advisory Commission (MedPAC) an important advisory panel to congress, voted to back a package of changes to
Read MoreCancer Doctors Recoil at Experimental Change in Drug Reimbursements
The Associated Press reports that medicare’s proposal for changes to reimbursement processes for chemotherapy and other drugs administered in the
Read MorePrescription Drug Costs Projected to Continue Upward Spiral
It’s no secret to anybody that the cost of prescription drugs is continuing its upward march–over 12% in 2014, with
Read MoreThe Medicare Impact of High-flying Drugs
Motley Fools, Sean Williams takes a look at the concentrated impact of a handful of drugs at the top of
Read More